Skip to main content
ImmuneCited

Quercetin pour Allergic Rhinitis

C Preuves Preuves limitées issues de petites études, mais certains signaux positifs existent.

Research suggests quercetin may inhibit mast cell degranulation and histamine release, providing natural antihistamine-like effects. It also acts as a zinc ionophore, potentially enhancing intracellular zinc concentration. Clinical evidence is emerging but still limited.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dquercetin\u0026condition\u003Dallergic\u002Drhinitis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

En conclusion

Research suggests quercetin may inhibit mast cell degranulation and histamine release, providing natural antihistamine-like effects. It also acts as a zinc ionophore, potentially enhancing intracellular zinc concentration. Clinical evidence is emerging but still limited.

Key Study Findings

Review
Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive Review.
Dose: None vs: None Outcome: None Effet: None None

Population: None

Observational Study
HMOX1 as a potential drug target for upper and lower airway diseases: insights from multi-omics …
Dose: None vs: None Outcome: HMOX1 causal relationship with airway diseases Effet: CRSwNP OR 0.945, AR OR 0.997, AS OR 0.935 p=0.044, p=0.007, p=0.003

Population: CRSwNP, allergic rhinitis, asthma (MR analysis)

Meta-Analysis n=823
Clinical Effects of Polyphenolic Compounds on Allergic Rhinitis: A Systematic Review and Meta-Analysis.
Dose: None vs: Placebo or control Outcome: Total nasal symptom scores in allergic rhinitis Effet: SMD=0.75 0.0001

Population: Patients with seasonal or perennial allergic rhinitis

In Vitro
In-silico exploring pathway and mechanism-based therapeutics for allergic rhinitis: Network pharmacology, molecular docking, ADMET, quantum …
Dose: None vs: None Outcome: Binding affinity to NFKB1, TRAF6, IL5, IL6 Effet: Predicted IC50 <50 nM None

Population: In silico/computational models

Other
Network pharmacology analysis of the Huangqi-Gancao herb pair reveals quercetin as a therapeutics for allergic …
Dose: None vs: OVA-induced AR mice without treatment Outcome: Allergic rhinitis symptoms and histopathology Effet: None None

Population: OVA-induced allergic rhinitis mouse model

Key Statistics

5

Études

400

Participants

Positive

C

Note

Referenced Papers

Pharmaceuticals (Basel, Switzerland) 2024 14 citations
Medicines (Basel, Switzerland) 2021 16 citations
Allergy, asthma, and … 2020 152 citations
Medicines (Basel, Switzerland) 2020 24 citations
Molecules (Basel, Switzerland) 2016 395 citations
Evidence-based complementary and … 2013 33 citations
Alternative medicine review … 2000

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
500-1,000 mg/day
immunesupport:
500-1,500 mg/day

Limite supérieure : No established UL; GRAS up to 500 mg/day per FDA

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Positive 823
None -- Positive --
None -- Positive --
None -- Positive --
Quertal + antihistamines 12 weeks Positive 100

Moment optimal de prise : With meals (fat-containing meals improve absorption); often paired with vitamin C or bromelain for enhanced bioavailability

Safety & Side Effects

Effets indésirables signalés

  • Headache
  • Tingling in extremities
  • Gastrointestinal discomfort
  • Low oral bioavailability (addressed by phytosome formulations)

Interactions connues

  • Cyclosporine (may increase drug levels)
  • Fluoroquinolone antibiotics (may interfere with bacterial target)
  • CYP3A4 and CYP2C8 substrates (may inhibit metabolism)

Apport maximal tolérable : No established UL; GRAS up to 500 mg/day per FDA

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Quercetin help with Allergic Rhinitis?
Based on 5 studies with 400 participants, there is limited but promising evidence that Quercetin may support Allergic Rhinitis management. Our evidence grade is C (Some Evidence).
How much Quercetin should I take for Allergic Rhinitis?
Studies have used various dosages. A commonly studied range is 500-1,000 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Quercetin?
Reported side effects may include Headache, Tingling in extremities, Gastrointestinal discomfort, Low oral bioavailability (addressed by phytosome formulations). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Quercetin and Allergic Rhinitis?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Autres ingrédients pour Allergic Rhinitis

References

  1. [1] Matteo Naso et al.. Nutrients. 2025. Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergic Diseases Based on a Narrative Review. doi:10.3390/nu17091476 PubMed
  2. [2] Enhao Wang et al.. Respir Res. 2025. HMOX1 as a potential drug target for upper and lower airway diseases: insights from multi-omics analysis. doi:10.1186/s12931-025-03124-w PubMed
  3. [3] K M Tanjida Islam et al.. Comput Biol Med. 2025. In-silico exploring pathway and mechanism-based therapeutics for allergic rhinitis: Network pharmacology, molecular docking, ADMET, quantum chemistry and machine learning based … doi:10.1016/j.compbiomed.2025.109754 PubMed
  4. [4] Alessandra Gori et al.. J Clin Med. 2025. Synergic Efficacy of a Multicomponent Nutraceutical Add-On Therapy in Seasonal Allergic Rhinitis in Children: A Prospective, Randomized, Parallel-Group Study. doi:10.3390/jcm14051517 PubMed
  5. [5] Yongjun Deng et al.. Naunyn Schmiedebergs Arch Pharmacol. 2025. Network pharmacology analysis of the Huangqi-Gancao herb pair reveals quercetin as a therapeutics for allergic rhinitis via the RELA-regulated IFNG/IRF1 … doi:10.1007/s00210-024-03353-8 PubMed
  6. [6] Yun-Ru Lai et al.. J Allergy Clin Immunol Pract. 2025. Clinical Effects of Polyphenolic Compounds on Allergic Rhinitis: A Systematic Review and Meta-Analysis. doi:10.1016/j.jaip.2025.06.032 PubMed
  7. [7] Sihong Huang et al.. Curr Comput Aided Drug Des. 2025. Exploration of Potential Targets and Molecular Mechanisms of the Yiqi Jianpi Tongqiao Formula in Treating Allergic Rhinitis Mouse Model based … doi:10.2174/0115734099299714240516160158 PubMed
  8. [8] Maria A Tosca et al.. Minerva Pediatr (Torino). 2025. A multicomponent food supplement with quercetin Phytosome®, zinc and vitamin C may be favorable in managing children with seasonal allergic … doi:10.23736/S2724-5276.25.07806-1 PubMed
  9. [9] Pilar Zafrilla et al.. Nutrients. 2025. Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive Review. doi:10.3390/nu17223506 PubMed
  10. [10] Zeyi Lv et al.. Front Pharmacol. 2025. Quercetin exhibits multi-target anti-allergic effects in animal models: a systematic review and meta-analysis of preclinical studies. doi:10.3389/fphar.2025.1673712 PubMed
  11. [11] Shan Liu et al.. Medicine (Baltimore). 2025. Potential mechanism of Qigebikang tablets in the treatment of allergic rhinitis: Network pharmacology and molecular docking. doi:10.1097/MD.0000000000044321 PubMed
  12. [12] Yue-Lin Zhang et al.. Curr Pharm Des. 2025. Mechanistic Insights into Qiangjie Xinyi Decoction for Northwest Dryness Syndrome with Allergic Rhinitis: Network Pharmacology and Experimental Validation Methods. doi:10.2174/0113816128394375250903053555 PubMed
  13. [13] Yumei Zhou et al.. Sci Rep. 2025. Combining AlphaFold-based AI docking with omics technologies preliminarily unveils the mechanism of Guominkang in treating allergic rhinitis. doi:10.1038/s41598-025-21298-7 PubMed
  14. [14] Dehong Mu et al.. Sci Rep. 2024. Quercetin-crosslinked chitosan nanoparticles: a potential treatment for allergic rhinitis. doi:10.1038/s41598-024-54501-2 PubMed
  15. [15] Mohd Farhan et al.. Pharmaceuticals (Basel). 2024. Dietary Polyphenols, Plant Metabolites, and Allergic Disorders: A Comprehensive Review. doi:10.3390/ph17060670 PubMed
  16. [16] Maja Friščić et al.. Acta Pharm. 2024. Total phenolic content, flavonoid content and antioxidant potential of Petasites hybridus and related species from Croatia and considerations regarding their … doi:10.2478/acph-2024-0032 PubMed
  17. [17] Xia Ke et al.. Autoimmunity. 2023. Quercetin improves the imbalance of Th1/Th2 cells and Treg/Th17 cells to attenuate allergic rhinitis. doi:10.1080/08916934.2023.2189133 PubMed
  18. [18] Anna Dębińska et al.. Nutrients. 2023. Dietary Polyphenols-Natural Bioactive Compounds with Potential for Preventing and Treating Some Allergic Conditions. doi:10.3390/nu15224823 PubMed
  19. [19] Sina Kaag et al.. Cells. 2023. Effects of Dietary Components on Mast Cells: Possible Use as Nutraceuticals for Allergies? doi:10.3390/cells12222602 PubMed
  20. [20] Amane Otaki et al.. Medicines (Basel). 2023. Quercetin-Induced Enhancement of Nasal Epithelial Cells' Ability to Produce Clara Cell 10-kD Protein In Vitro and In Vivo. doi:10.3390/medicines10040028 PubMed
  21. [21] Jinjun Cheng et al.. J Ethnopharmacol. 2022. Integrative analysis of network pharmacology and proteomics to identify key targets of Tuomin-Zhiti-Decoction for allergic rhinitis. doi:10.1016/j.jep.2022.115448 PubMed
  22. [22] Warangkana Arpornchayanon et al.. Asian Pac J Allergy Immunol. 2022. Antiallergic activities of shallot (Allium ascalonicum L.) and its therapeutic effects in allergic rhinitis. doi:10.12932/AP-300319-0529 PubMed
  23. [23] Ji Cheng et al.. Immunopharmacol Immunotoxicol. 2022. Quercetin attenuates lipopolysaccharide-mediated inflammatory injury in human nasal epithelial cells via regulating miR-21/DMBT1/NF-κB axis. doi:10.1080/08923973.2021.1988963 PubMed
  24. [24] Minye Qu et al.. Evid Based Complement Alternat Med. 2022. Network Pharmacology and Molecular Docking Study of Yupingfeng Powder in the Treatment of Allergic Diseases. doi:10.1155/2022/1323744 PubMed
  25. [25] Li-Jie Qi et al.. Biomed Res Int. 2022. Molecular Mechanisms Underlying the Effects of Bimin Kang Mixture on Allergic Rhinitis: Network Pharmacology and RNA Sequencing Analysis. doi:10.1155/2022/7034078 PubMed
  26. [26] Takayuki Okumo et al.. Medicines (Basel). 2021. Inhibition of Angiogenic Factor Productions by Quercetin In Vitro and In Vivo. doi:10.3390/medicines8050022 PubMed
  27. [27] Jin A Shin et al.. Phytomed Plus. 2021. The potential of BEN815 as an anti-inflammatory, antiviral and antioxidant agent for the treatment of COVID-19. doi:10.1016/j.phyplu.2021.100058 PubMed
  28. [28] Morteza Jafarinia et al.. Allergy Asthma Clin Immunol. 2020. Quercetin with the potential effect on allergic diseases. doi:10.1186/s13223-020-00434-0 PubMed
  29. [29] Yoshihito Tanaka et al.. Medicines (Basel). 2020. Modulation of Th1/Th2 Cytokine Balance by Quercetin In Vitro. doi:10.3390/medicines7080046 PubMed
  30. [30] Xiao Liang et al.. Evid Based Complement Alternat Med. 2020. Identification of Active Compounds of Mahuang Fuzi Xixin Decoction and Their Mechanisms of Action by LC-MS/MS and Network Pharmacology. doi:10.1155/2020/3812180 PubMed
  31. [31] Gianluigi Marseglia et al.. Ital J Pediatr. 2019. A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II. doi:10.1186/s13052-019-0678-y PubMed
  32. [32] Nachi Ebihara et al.. Evid Based Complement Alternat Med. 2018. Suppressive Effect of Quercetin on Nitric Oxide Production from Nasal Epithelial Cells In Vitro. doi:10.1155/2018/6097625 PubMed
  33. [33] Yukako Edo et al.. Medicines (Basel). 2018. Quercetin Enhances the Thioredoxin Production of Nasal Epithelial Cells In Vitro and In Vivo. doi:10.3390/medicines5040124 PubMed
  34. [34] Mustafa Sagit et al.. Eur Arch Otorhinolaryngol. 2017. Effectiveness of quercetin in an experimental rat model of allergic rhinitis. doi:10.1007/s00405-017-4602-z PubMed
  35. [35] Jiri Mlcek et al.. Molecules. 2016. Quercetin and Its Anti-Allergic Immune Response. doi:10.3390/molecules21050623 PubMed
  36. [36] Misako Kashiwabara et al.. BMC Complement Altern Med. 2016. Suppression of neuropeptide production by quercetin in allergic rhinitis model rats. doi:10.1186/s12906-016-1123-z PubMed
  37. [37] Shinji Irie et al.. In Vivo. 2016. Suppressive Activity of Quercetin on Periostin Functions In Vitro. PubMed
  38. [38] Yuki Nariai et al.. J Biol Chem. 2015. Disruption of Heat Shock Protein 90 (Hsp90)-Protein Kinase Cδ (PKCδ) Interaction by (-)-Maackiain Suppresses Histamine H1 Receptor Gene Transcription in … doi:10.1074/jbc.M115.657023 PubMed
  39. [39] Renato Ariano. Acta Biomed. 2015. Efficacy of a novel food supplement in the relief of the signs and symptoms of seasonal allergic rhinitis and in … PubMed
  40. [40] Misako Sakai-Kashiwabara et al.. Evid Based Complement Alternat Med. 2013. Inhibitory action of quercetin on eosinophil activation in vitro. doi:10.1155/2013/127105 PubMed
  41. [41] Masashi Hattori et al.. Int Immunopharmacol. 2013. Quercetin inhibits transcriptional up-regulation of histamine H1 receptor via suppressing protein kinase C-δ/extracellular signal-regulated kinase/poly(ADP-ribose) polymerase-1 signaling pathway in HeLa … doi:10.1016/j.intimp.2012.12.030 PubMed
  42. [42] Timothy Mainardi et al.. J Allergy Clin Immunol. 2009. Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. doi:10.1016/j.jaci.2008.12.023 PubMed
  43. [43] P Remberg et al.. Phytomedicine. 2004. Characteristics, clinical effect profile and tolerability of a nasal spray preparation of Artemisia abrotanum L. for allergic rhinitis. doi:10.1078/0944-7113-00350 PubMed
  44. [44] Raja Jaber. Prim Care. 2002. Respiratory and allergic diseases: from upper respiratory tract infections to asthma. doi:10.1016/s0095-4543(01)00008-2 PubMed
  45. [45] S M Thornhill et al.. Altern Med Rev. 2000. Natural treatment of perennial allergic rhinitis. PubMed
  46. [46] H Otsuka et al.. J Allergy Clin Immunol. 1995. Histochemical and functional characteristics of metachromatic cells in the nasal epithelium in allergic rhinitis: studies of nasal scrapings and their … doi:10.1016/s0091-6749(95)70297-0 PubMed

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.